Ginkgo Bioworks Launches Cell Development Kit Service for Standardized, Low-Cost Entry to its Cell Programming Platform
- Thursday, November 11, 2021, 7:00
- Finance
- Add a comment
BOSTON, Nov. 11, 2021 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced the launch of its Cell Development Kits (CDKs) service. CDKs provide streamlined access to the company’s platform for aspiring cell developers to…
About the Author
adminasapcorp has written 41562 stories on this site.